CTOs on the Move

ORIC Pharmaceuticals

www.oricpharma.com

 
ORIC was established in 2014 with a bold vision of Overcoming Resistance in Cancer. Resistance limits the efficacy of otherwise significant cancer treatment breakthroughs, regardless of modality. Our ambition at ORIC is to discover and develop innovative therapies that benefit patients with cancer, including by making existing therapies more effective for a longer period of time. Our initial project was a small molecule antagonist of the glucocorticoid receptor (GR), which has been implicated in resistance to various treatment modalities—including chemotherapy, immunotherapy, and anti-hormonal therapy—and across multiple cancers. The resulting product candidate, ORIC-101, is now being studied in clinical trials for ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.oricpharma.com
  • 240 East Grand Avenue 2nd Floor
    South San Francisco, CA USA 94080
  • Phone: 650.388.5600

Executives

Name Title Contact Details

Funding

ORIC Pharmaceuticals raised $50M on 02/21/2018

Similar Companies

MOVA Pharmaceuticals

MOVA Pharmaceuticals is a Caguas, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Produits Chimiques Delmar Inc

Produits Chimiques Delmar Inc is a Lasalle, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Headcan

Headcan is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Manhattan Research

Manhattan Research is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.